4//SEC Filing
AVADEL PHARMACEUTICALS PLC 4
Accession 0001140361-17-026876
$AVDLCIK 0001012477operating
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:27 PM ET
Size
11.4 KB
Accession
0001140361-17-026876
Insider Transaction Report
Form 4
NAVARRE CHRISTOPHE
Director
Transactions
- Award
Stock Option (right to buy)
2017-06-28$10.51/sh+30,000$315,300→ 30,000 totalExercise: $10.51From: 2018-06-28Exp: 2022-06-28→ ADSs (30,000 underlying)
Holdings
- 54,026
Warrants (right to buy
Exercise: $21.67From: 2016-06-26Exp: 2019-06-26→ ADSs (54,026 underlying) - 46,000
Warrants (right to buy)
Exercise: $14.54From: 2015-06-24Exp: 2018-06-24→ ADSs (46,000 underlying) - 54,026
Warrants (right to buy)
Exercise: $13.59From: 2017-08-10Exp: 2020-08-17→ ADSs (54,026 underlying)
Footnotes (5)
- [F1]Warrants were granted 06/24/2014 but were not exercisable until the first anniversary of the date of grant; on such first anniversary the warrants became exercisable for a 3-year period as to all 46,000 ADSs. The warrant exercise price per ADS may be paid in U.S. Dollars as shown in Item 4 of Table II or in Euros based on the exchange rate prevailing on the date of grant, or (euro)10.94 per ADS.
- [F2]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
- [F3]Warrants were granted 06/26/2015 but were not exercisable until the first anniversary of the date of grant; on such first anniversary the warrants became exercisable for a 3-year period as to all 54,026 ADSs. The warrant exercise price per ADS may be paid in U.S. Dollars as shown in Item 4 of Table II or in Euros based on the exchange rate prevailing on the date of grant, or (euro)19.34 per ADS.
- [F4]Warrants were granted 08/10/2016 but are not exercisable until the first anniversary of the date of grant; on such first anniversary the warrants will become exercisable for a 3-year period as to all 54,026 ADSs. The warrant exercise price per ADS may be paid in U.S. Dollars as shown in Item 4 of Table II or in Euros based on the exchange rate prevailing on the date of grant, or (euro) 12.16 per ADS. Warrants as to all 54,026 ADSs vest on 08/10/2017.
- [F5]Options become exercisable as to all 30,000 ADSs on the first anniversary of the 06/28/2017 grant date.
Documents
Issuer
AVADEL PHARMACEUTICALS PLC
CIK 0001012477
Entity typeoperating
Related Parties
1- filerCIK 0001012477
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 4:27 PM ET
- Size
- 11.4 KB